Tech Optimist Episode #60: Meet the Startup Focused on Microbe-Tech
Concerto Biosciences is transforming how we use microbes to develop innovative products for health, agriculture, and beyond
Tech Optimist, presented by Alumni Ventures, focuses on the intersection of technology, entrepreneurship, and innovation. We are passionate about technology and its potential to drive positive change. We explore our lane through with founders, investors, and futurists; discussions of new innovations; and reviews of trends in technology and venture capital. Subscribe Here »
In this episode, Alumni Ventures Senior Associate Drew Wandzilak connects with Cheri Ackerman, CEO of Concerto Biosciences. Based in Cambridge, Massachusetts, Concerto is transforming how we use microbes to develop innovative products for health, agriculture, and beyond.
Cheri dives into their groundbreaking technology, kChip, which tests millions of microbial combinations to discover effective microbial ecosystems. She discusses their clinical trials focused on conditions like eczema and yeast infections, emphasizing Concerto’s long-term vision of leveraging microbes to create sustainable, biology-based solutions.
The conversation explores how Concerto aims to shift our understanding of microbes — from adversaries to powerful allies — reshaping industries and improving lives with their advanced biotech solutions. Tune in to discover the future potential of microbial innovation.
Listen Here »
Alumni Ventures offers accredited individuals access to professional-grade venture capital, a key asset class missing from the portfolios of many sophisticated investors. Since 2014, AV has raised $1.3+ billion from 10,000+ investors and backed 1,400+ unique portfolio companies. AV is a top 20 venture firm in North America according to CB Insights, as well as the #1 most active venture firm in the U.S., and #3 most active in the world, according to PitchBook’s 2022 and 2023 rankings. AV has won awards from Inc. Magazine, Fast Company, Benzinga, and the US FinTech Awards.
